Australia markets closed

Nuvectis Pharma, Inc. (NVCT)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
6.50-0.25 (-3.70%)
At close: 04:00PM EDT
6.50 0.00 (0.00%)
After hours: 04:34PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
Total revenue
0
0
0
0
Operating expenses
Research development
14,354
15,380
13,227
9,545
Selling general and administrative
7,709
7,517
6,007
3,349
Total operating expenses
22,063
22,897
19,234
12,894
Operating income or loss
-22,063
-22,897
-19,234
-12,894
Income before tax
-21,102
-22,260
-19,085
-12,890
Income from continuing operations
-21,102
-22,260
-19,085
-12,890
Net income
-21,102
-22,260
-19,085
-12,890
Net income available to common shareholders
-21,102
-22,260
-19,085
-12,890
Basic EPS
-1.50
-1.43
-1.51
-1.09
Diluted EPS
-1.50
-1.43
-1.51
-1.09
Basic average shares
15,172
15,557
12,658
12,718
Diluted average shares
15,172
15,557
12,658
12,718